John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, chairs a discussion with Anas Younes, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, on the highlights from the first day of the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2015 meeting.
Discussion topics include advances in targeting the tumor microenvironment through immune checkpoint inhibitors, alone or in combination, as a therapeutic strategy for non-Hodgkin lymphoma; and the efforts and challenges to further understand T-cell and B-cell lymphoma biology and underlying molecular events for the development of personalized medicine.
Get great new content delivered to your inboxSign up
By choosing to continue, you are confirming that you are a healthcare professional
Please enter your details if you would like to receive the latest Hemonc news and updates